Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
40.8M
-
Shares change
-
-244K
-
Total reported value, excl. options
-
$532M
-
Value change
-
-$2.99M
-
Put/Call ratio
-
0.2
-
Number of buys
-
64
-
Number of sells
-
-57
-
Price
-
$13.05
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q1 2024
146 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q1 2024.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40.8M shares
of 63.2M outstanding shares and own 64.65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.3M shares), BlackRock Inc. (3.7M shares), MORGAN STANLEY (3.29M shares), ARMISTICE CAPITAL, LLC (2.4M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.33M shares), PERCEPTIVE ADVISORS LLC (2.3M shares), MILLENNIUM MANAGEMENT LLC (2.04M shares), CIBC Private Wealth Group, LLC (1.85M shares), EMERALD ADVISERS, LLC (1.56M shares), and TimesSquare Capital Management, LLC (1.38M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.